| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R33EY034345 | Overcome the barriers of vision care in Africa using smartphones | 000 | 3 | NIH | 10/10/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $14,471,108 ) (Continued on the next page) |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY020581 | Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy | 000 | 15 | NIH | 7/19/2024 | $632,258 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY012963 | Mechanisms of Sensitization in High Risk Corneal Grafts | 000 | 25 | NIH | 7/16/2024 | $671,244 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | U01NS119560 | Humanization of a Notch 3 Agonist Antibody for Pre-Clinical Development of a CADASIL Treatment | 001 | 2 | NIH | 4/10/2024 | $60,462 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | U01NS119560 | Humanization of a Notch 3 Agonist Antibody for Pre-Clinical Development of a CADASIL Treatment | 000 | 2 | NIH | 2/13/2024 | $737,787 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | P30EY003790 | Core Grant for Vision Research | 001 | 43 | NIH | 8/28/2024 | $947,710 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY034111 | Mechanisms of immunological memory-mediated pathogenesis in chronic autoimmune uveitis | 000 | 2 | NIH | 4/18/2024 | $492,500 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY026539 | Investigation of endomucin as a novel regulator of angiogenesis | 000 | 8 | NIH | 7/15/2024 | $500,479 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | T32EY007145 | Training Program in the Molecular Bases of Eye Disease | 002 | 25 | NIH | 7/15/2024 | $186,846 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY005665 | Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis | 002 | 39 | NIH | 8/9/2024 | $616,322 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY029727 | Contribution of Mast Cells in Non-Allergic Ocular Inflammation | 002 | 6 | NIH | 5/22/2024 | $492,500 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY035312 | Mechanisms of microglial neuroinflammatory response in glaucoma | 000 | 2 | NIH | 8/5/2024 | $492,500 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY035215 | Immune Mechanisms of Chronic Ocular Damage after Acute Exposure to Nitrogen Mustard | 000 | 1 | NIH | 9/3/2024 | $589,071 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY031696 | Innate and Adaptive Immunity in the Pathogenesis of Glaucoma | 001 | 4 | NIH | 9/6/2024 | $717,827 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY031696 | Innate and Adaptive Immunity in the Pathogenesis of Glaucoma | 000 | 3 | NIH | 6/28/2024 | $140,834 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY032762 | Fas Ligand Cleavage regulates ocular homeostasis and glaucoma | 000 | 3 | NIH | 1/30/2024 | $600,249 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY034833 | Tissue Hypoxia and Topical Oxygen Therapy in Ocular Mustard Gas Injury | 000 | 2 | NIH | 8/14/2024 | $296,810 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | F32EY033211 | Regulating cell-cell interactions to improve donor retinal ganglion cell integration | 001 | 3 | NIH | 6/7/2024 | $4,964 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | F32EY033211 | Regulating cell-cell interactions to improve donor retinal ganglion cell integration | 000 | 3 | NIH | 1/26/2024 | $74,492 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY024602 | Ocular Immune Regulation by Mesenchymal Stem Cells | 000 | 10 | NIH | 3/13/2024 | $492,500 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | K99EY034938 | Partial epigenetic reprogramming of retinal pigment cells in age-related degeneration, dysfunction, and injury | 000 | 2 | NIH | 6/28/2024 | $114,039 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY020889 | Immunopathogenic mechanisms of dry eye disease | 000 | 14 | NIH | 11/29/2023 | $492,500 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | K99EY033830 | Mechanisms of corneal stromal activation during regeneration and fibrosis by exosomes | 000 | 2 | NIH | 8/5/2024 | $120,085 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY036222 | Developing Equitable Deep Learning Models for Automated Glaucoma Screening | 000 | 1 | NIH | 9/5/2024 | $754,779 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY023385 | Visual Field Expansion Through Innovative Multi-periscopic Prism Design (AD) | 001 | 10 | NIH | 9/9/2024 | $107,077 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01AI179898 | Characterization and optimization of single dose, thermostable and durable vaccine platform towards increased clinical acceptance | 001 | 1 | NIH | 9/13/2024 | $64,432 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R61NS131303 | Topical Neurokinin-1 Receptor Antagonist as an Effective Non-addictive Analgesic for Ocular Pain | 000 | 1 | NIH | 8/5/2024 | $1,559,917 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY025677 | Scanning and Detection at Intersections | 000 | 9 | NIH | 8/29/2024 | $690,566 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R33EY034345 | Overcome the barriers of vision care in Africa using smartphones | 000 | 3 | NIH | 8/12/2024 | $392,247 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01AI179898 | Characterization and optimization of single dose, thermostable and durable vaccine platform towards increased clinical acceptance | 000 | 1 | NIH | 8/23/2024 | $604,137 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY033288 | The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival | 000 | 3 | NIH | 8/23/2024 | $492,500 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY035947 | VRC Inhibiting p38 to Prevent and Restore Corneal Scarring | 001 | 2 | NIH | 8/19/2024 | $261,431 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | F32EY035529 | Sex difference in conjunctival epithelial cell response and their profile of extracellular bioactive lipids duringallergic inflammation | 000 | 2 | NIH | 7/16/2024 | $76,756 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R13EY036700 | 33rd Biennial Cornea Conference | 000 | 1 | NIH | 7/22/2024 | $45,000 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY034345 | Overcome the barriers of vision care in Africa using smartphones | 000 | 2 | NIH | 7/5/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R00EY028631 | Relationship between Glaucoma and the Three-Dimensional Optic Nerve Head Related Structure | 000 | 5 | NIH | 8/19/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY035947 | VRC Inhibiting p38 to Prevent and Restore Corneal Scarring | 000 | 1 | NIH | 2/28/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY023385 | Visual Field Expansion Through Innovative Multi-periscopic Prism Design (AD) | 000 | 10 | NIH | 2/15/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY035298 | Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for Glaucoma | 000 | 1 | NIH | 12/1/2023 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | P30EY003790 | Core Grant for Vision Research | 000 | 42 | NIH | 4/5/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | T32EY007145 | Training Program in the Molecular Bases of Eye Disease | 001 | 24 | NIH | 7/11/2024 | $64,598 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY005665 | Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis | 001 | 38 | NIH | 8/9/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY029727 | Contribution of Mast Cells in Non-Allergic Ocular Inflammation | 001 | 5 | NIH | 3/1/2024 | $157,832 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | UG3NS131518 | Anesthetic-Eluting Contact Lens for Corneal Pain | 000 | 1 | NIH | 7/17/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY034345 | Overcome the barriers of vision care in Africa using smartphones | 000 | 2 | NIH | 7/5/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY031777 | Monocular Visual Confusion for Field Expansion | 000 | 4 | NIH | 2/1/2024 | $0 |
| | 2024 | 2022 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY029727 | Contribution of Mast Cells in Non-Allergic Ocular Inflammation | 000 | 4 | NIH | 3/1/2024 | -$157,832 |
| | 2024 | 2022 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY031781 | Pathogenicity of memory Th17 cells in chronic autoimmune uveitis | 000 | 2 | NIH | 4/11/2024 | $0 |
|
